OPTION AGREEMENT BETWEENOption Agreement • October 17th, 1997 • Vysis Inc • California
RECITALSLicense Agreement • October 17th, 1997 • Vysis Inc • California
UNDERWRITING AGREEMENTUnderwriting Agreement • January 30th, 1998 • Vysis Inc • In vitro & in vivo diagnostic substances • New York
STOCKHOLDER AGREEMENT STOCKHOLDER AGREEMENT (this "AGREEMENT"), dated as of October 24, 2001 by and among Abbott Laboratories, an Illinois corporation ("PARENT"), Rainbow Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of...Stockholder Agreement • October 31st, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Delaware
REGISTRATION RIGHTS AGREEMENT THIS AGREEMENT, made as of February 5, 1998, is by and between Vysis, Inc., a Delaware corporation (the "Company"), and Amoco Technology Company, a Delaware corporation (the "Stockholder"). This Agreement is made in...Registration Rights Agreement • March 30th, 1998 • Vysis Inc • In vitro & in vivo diagnostic substances • Delaware
INTEGRATED GENETICS LOGO] Confidential treatment requested for portions of this document, portions for which confidential treatment is requested are noted. LICENSE AGREEMENT ----------------- AGREEMENT made and effective by and between YALE...License Agreement • March 29th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Connecticut
CONFIDENTIALITY AGREEMENTConfidentiality Agreement • October 31st, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances
REGISTRATION RIGHTS AGREEMENT THIS AGREEMENT, made as of ________, 1997, is by and between Vysis, Inc., a Delaware corporation (the "Company"), and Amoco Technology Company, a Delaware corporation (the "Stockholder"). This Agreement is made in...Registration Rights Agreement • October 17th, 1997 • Vysis Inc • Delaware
BETWEENExclusive License Agreement • October 17th, 1997 • Vysis Inc • California
WITNESSETHLicense Agreement • December 9th, 1997 • Vysis Inc • In vitro & in vivo diagnostic substances • New York
SUBLICENSE AGREEMENTSublicense Agreement • January 30th, 1998 • Vysis Inc • In vitro & in vivo diagnostic substances • Massachusetts
JOINT FILING AGREEMENT This will confirm the agreement by and between the undersigned that the Schedule 13D filed on or about this date and any amendments thereto with respect to beneficial ownership by the undersigned of shares of the Common Stock,...Joint Filing Agreement • November 1st, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances
This will confirm the agreement by and between the undersigned that the Schedule 13D filed on or about this date and any amendments thereto with respect to beneficial ownership by the undersigned of shares of the Common Stock, par value $.001 per share, of Vysis, Inc. is being filed on behalf of each of the undersigned under the Securities Exchange Act of 1934, as amended. This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
AGREEMENT AND PLAN OF MERGER DATED AS OF OCTOBER 24, 2001 AMONG ABBOTT LABORATORIES RAINBOW ACQUISITION CORP. AND VYSIS, INC. TABLE OF CONTENTSMerger Agreement • October 31st, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Delaware
TABLE OF CONTENTSResearch and License Agreement • October 17th, 1997 • Vysis Inc • New York
INDUSTRIAL BUILDING LEASE LANDLORD AMERICAN NATIONAL BANK AND TRUST COMPANY OF CHICAGO, not personally but as Trustee under Trust Agreement dated December 30, 1985 and known as Trust No. 66360 TENANT: VYSIS, INC., an Illinois corporation LEASED...Industrial Building Lease • December 9th, 1997 • Vysis Inc • In vitro & in vivo diagnostic substances
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 17th, 1997 • Vysis Inc • California
COOPERATION AGREEMENT THIS COOPERATION AGREEMENT is made the 19th day of January, 1998, between VYSIS, INC. ("Vysis"), a Delaware corporation, and AMOCO TECHNOLOGY COMPANY ("ATC"), a Delaware corporation. WHEREAS, Vysis is a former wholly-owned...Cooperation Agreement • January 30th, 1998 • Vysis Inc • In vitro & in vivo diagnostic substances • Illinois
EXCLUSIVE LICENSE AGREEMENT BETWEEN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AND VYSIS, INC. FOR MOLECULAR CYTOGENETICS SOFTWARE TABLE OF CONTENTSExclusive License Agreement • October 17th, 1997 • Vysis Inc • California
OPTION AGREEMENT FOR THE GLASS CHROMOSOMEOption Agreement • October 17th, 1997 • Vysis Inc • California
THIS OPTION AGREEMENT ("Agreement") is made and is effective this 3rd day of April 1996, by and between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation having its statewide administrative offices at 300 Lakeside Drive, 22nd Floor, Oakland, California 94612-3550 ("The Regents"), and VYSIS, INC., an Illinois corporation, having a principal place of business at 3100 Woodcreek Drive, Downers Grove, Illinois 60511 ("Optionee").
ASSET PURCHASE, LICENSE, AND DISTRIBUTION AGREEMENT MARKED, REDACTED COPY ASSET PURCHASE, LICENSE, AND DISTRIBUTION AGREEMENTAsset Purchase, License, and Distribution Agreement • August 16th, 1999 • Vysis Inc • In vitro & in vivo diagnostic substances • California
Director’s AgreementDirector's Agreement • May 15th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Delaware
WHEREAS, Vysis and Mr. Dewey wish to set out the terms of compensation for Mr. Dewey’s service upon his election to Vysis’ Board of Directors (“Board”), and for certain consulting services provided by Mr. Dewey before his election as a member of Vysis’ Board.
DIRECTOR'S AGREEMENT This Director's Agreement between Vysis, Inc. ("Vysis"), a Delaware corporation, and Dr. Richard A. Lerner is effective February 1, 2000. WHEREAS, Vysis and Dr. Lerner wish to set out the terms of compensation for Dr. Lerner's...Director's Agreement • March 29th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Delaware
Director’s AgreementDirector's Agreement • November 14th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances
WHEREAS, Vysis and Dr. Quanstrom wish to set out the terms of compensation for Dr. Quanstrom’s service on Vysis’ Board of Directors after his retirement from employment with BP Amoco p.l.c.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 20th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Michigan
This Asset Purchase Agreement (this "Agreement"), effective as of July 31, 2001, is made by and among Vysis, Inc. ("VYSIS"), a Delaware corporation with its principal place of business at 3100 Woodcreek Drive, Downers Grove, Illinois, Gene-Trak, Inc. ("GTI"), a Delaware corporation with its principal place of business at 3100 Woodcreek Drive, Downers Grove, Illinois, Gene-Trak Systems Industrial Diagnostics Corporation ("GENE-TRAK"), a Delaware corporation with its principal place of business at 94 South St., Hopkinton, Massachusetts, and Neogen Corporation ("NEOGEN"), a Michigan corporation with its principal place of business at 620 Lesher Place, Lansing, Michigan 48912. VYSIS, GTI and GENE-TRAK are collectively referred to herein as "SELLERS". The SELLERS and NEOGEN are sometimes referred to herein as the "Parties."
EMPLOYMENT AGREEMENTEmployment Agreement • August 14th, 2001 • Vysis Inc • In vitro & in vivo diagnostic substances • Illinois
This AGREEMENT is made this 24th day of June, 1998, by and between VYSIS, INC., a corporation formed and existing under the laws of the State of Delaware, with its principal place of business at 3100 Woodcreek Drive, Downers Grove, IL 60515 (hereinafter referred to as the "Employer"), and PAUL STEUPERAERT, an individual residing at Les Regourdes, Le Faget, F-31460, Caraman, France (hereinafter referred to as the "Employee").
TAX ALLOCATION AGREEMENT This Agreement is entered into as of July 30, 1997, by and between Amoco Corporation, an Indiana corporation ("Amoco"), and Vysis, Inc., a Delaware corporation ("Vysis"). WHEREAS, Amoco and Vysis are part of an affiliated...Tax Allocation Agreement • October 17th, 1997 • Vysis Inc
VYSIS, INC.Non-Qualified Stock Option Agreement • March 30th, 2000 • Vysis Inc • In vitro & in vivo diagnostic substances
SOFTWARE DEVELOPMENT AND MARKETING AGREEMENT This Software Development and Marketing Agreement is between Digital Scientific Limited ("Digital"), a corporation under the laws of the United Kingdom, and Vysis, Inc. ("Vysis''), a corporation under the...Software Development and Marketing Agreement • October 17th, 1997 • Vysis Inc • Illinois
AMENDED AND RESTATED TAX ALLOCATION AGREEMENT This amended and restated Agreement is entered into as of January 19, 1998, by and between Amoco Corporation, an Indiana corporation ("Amoco"), and Vysis, Inc., a Delaware corporation ("Vysis"). WHEREAS,...Tax Allocation Agreement • January 30th, 1998 • Vysis Inc • In vitro & in vivo diagnostic substances
